Sandalova, Sofya, et al. “Early Post-Marketing Safety Signals of Anifrolumab in EudraVigilance: A Belimumab-Comparator Disproportionality Analysis”. International Journal of Medical Students, Aug. 2026, https://ijms.info/IJMS/article/view/4785.